Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

Author： Stiefel Gary

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.33, Iss.10, 2010-10, pp. : 821-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

By Bangs Mark E. Jin Ling Zhang Shuyu Desaiah Durisala Allen Albert J. Read Holly A. Regev Arie Wernicke Joachim F.

Drug Safety, Vol. 31, Iss. 4, 2008-01 ,pp. : 345-354

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Attention-Deficit Hyperactivity Disorder with Methylphenidate

By Wolraich M.L. Doffing M.A.

CNS Drugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 243-250

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D. Plosker G.L.

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P. Keating Gillian M.

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P. Keating Gillian M.

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite